Detection of high risk human papillomavirus DNA sequences in head and neck squamous cell carcinoma in Iranian Fanconi anemia patients

Yakhteh

Volumn 12, Issue 1, 2010, Pages

  Haratian, Kaveh ^a   Meybodi, Anahita Mohseni ^b   Moradi, Shabnam Zari ^b   Vosough, Parvaneh ^c  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Fanconi anemia; Head and neck carcinoma; Human papillomavirus; Squamous cell carcinoma

Indexed keywords

VIRUS ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA SEQUENCE; FANCONI ANEMIA; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IRAN; MALE; MOUTH CAVITY; NONHUMAN; OROPHARYNX; POLYMERASE CHAIN REACTION; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; SQUAMOUS CELL CARCINOMA; VIRUS INFECTION; WART VIRUS;

EID: 77953593686     PISSN: 15614921     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Kennedy RD, D'Andrea AD. The Fanconi anemia/BRCA pathway: new faces in the crowd. Genes Dev. 2005; 19: 2925-2940.
2. Taniguchi T, D'Andrea A. Molecular pathogenesis of Fanconi anemia: recent progress. Blood. 2006; 107: 4223-4233. (Pubitemid 43801344)
3. Alter BP. Fanconi's anemia and malignancies. Am J Hematol. 1996; 53: 99-110.
4. Alter BP. Cancer in Fanconi anemia, 1927-2001. Cancer. 2003; 97: 425-440.
5. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood. 2003; 101: 822-826. (Pubitemid 36139345)
6. Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood. 2003; 101: 1249-1256. (Pubitemid 36182492)
7. Kutler DI, Auerbach AD, Satagopan J, Giampietro PF, Batish SD, Huvos AG, et al. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg. 2003; 129: 106-112.
8. Ries LA. Rates. In: Harras A (editor). Cancer: rates and risks. Washington (DC): National Institutes of Health; 1996; 9-55.
9. Maier H, Sennewald E, Heller GF, Weidauer H. Chronic alcohol consumption-the key risk factor for pharyngeal cancer. Otolaryngol Head Neck Surg. 1994; 110: 168-173.
10. Ragin CCR, Modugno F, Gollin SM. The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus. J Dent Res. 2007; 86: 104-114.
11. Gillison ML, Shah KV. Chapter 9: Role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr. 2003; 31: 57-65.
12. Herrero R. Chapter 7: Human papillomavirus and cancer of the upper aeradigestive tract. J Natl Cancer Inst Monogr. 2003; 31: 47-51.
13. Syrjanen K, Syrjanen S, Lamberg M, Pyrhonen S, Nuutinen J. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg. 1983; 12: 418-424. (Pubitemid 14141093)
14. Schwartz SM, Daling JR, Doody DR, Wipf GC, Carter JJ, Madeleine MM, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst. 1998; 90: 1626-1636.
15. Smith EM, Hoffman HT, Summersgill KS, Kirchner HL, Turek LP, Haugen TH. Human papillomavirus and risk of oral cancer. Laryngoscope. 1998; 108: 1098-1103.
16. Smith EM, Ritchie JM, Summersgill KF, Hoffman HT, Wang DH, Haugen TH, et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst. 2004; 96: 449-455.
17. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001; 344: 1125-1131. (Pubitemid 32285233)
18. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003; 95: 1772-1783. (Pubitemid 38008900)
19. Hansson BG, Rosenquist K, Antonsson A, Wennerberg J, Schildt EB, Bladström A, et al. Strong association between infections with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol. 2005; 125: 1337-1344.
20. Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilczynski SP. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer. 1997; 79: 595-604.
21. Haraf DJ, Nodzenski E, Brachman D, Mick R, Montag A, Graves D, et al. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res. 1996; 2: 755-762.
22. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000; 92: 709-720. (Pubitemid 30365531)
23. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer. 2001; 92: 805-813. (Pubitemid 32783066)
24. Kutler DI, Wreesmann VB, Goberdhan A, Ben-Porat L, Satagopan J, Ngai I, et al. Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst. 2003; 95: 1718-1721. (Pubitemid 37509080)
25. Narayan G, Arias-Pulido H, Nandula SV, Basso K, Sugirtharaj DD, Vargas H, et al. Promoter hypermethylation of FANCF: disruption of Fanconi anemia-BRCA pathway in cervical cancer. Cancer Res. 2004; 64: 2994-2997. (Pubitemid 38581394)
26. Lowy DR, Gillison ML. A new link between Fanconi anemia and human papillomavirus-associated malignancies. J Natl Cancer Inst. 2003; 95: 1648-1650.
27. Jacobs MV, Snijders PJF, van den Brule AJC, Helmerhorst TJM, Meijer CJLM, Walboomers JM. MA general primer GP5+/GP6+-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol. 1997; 35: 791-795.
28. Bauer HM, Greer CE, Manos MM. Determination of genital HPV infection using consensus PCR. In CS Herrington McGee (editors). Diagnostic Molecular Pathology: a Practical Approach. Oxford: Oxford University Press. 1992; 131-152.
29. Heim K, Widschwendter A, Pirschner G, Wieland U, Awerkiew S, Christensen ND, et al. Antibodies to human papillomavirus 16 L1 virus-like particles as an independent prognostic marker in cervical cancer. Am J Obstet Gynecol. 2002; 186: 705-711. (Pubitemid 34494350)
30. Fouret P, Monceaux G, Temam S, Lacourreye L, St Guily JL. Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch Otolaryngol Head Neck Surg. 1997; 123: 513-516. (Pubitemid 27212848)
31. Koyama K, Uobe K and Tanaka A. Highly sensitive detection of H PV-DNA in paraffin sections of human oral carcinomas. J Oral Pathol Med. 2007; 36: 18-24. (Pubitemid 44973983)
32. Steinberg BM, DiLorenzo TP. A possible role for human papillomaviruses in head and neck cancer. Cancer Metastasis Rev. 1996; 15: 91-112. (Pubitemid 26248353)
33. Niedobitek G, Pitteroff S, Herbst H, Shepherd P, Finn T, Anagnostopoulos I, et al. Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. J Clin Pathol. 1990; 43: 918-921. (Pubitemid 20359873)
34. Wilczynski SP, Lin BT, Xie Y, Paz IB. Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol. 1998; 152: 145-156. (Pubitemid 28028055)
35. Snijders PJ, Cromme FV, van den Brule A, Schrijnemakers HF, Snow GB, Meijer CJ, et al. Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer. 1992; 51: 845-850.
36. Van Zeeburg HJ, Snijders PJ, Pals G, Hermsen MA, Rooimans MA, Bagby G, et al. Generation and Molecular Characterization of Head and Neck Squamous Cell Lines of Fanconi Anemia Patients. Cancer Res. 2005; 65: 1271-1276.
37. Van Zeeburg HJ, Snijders PJ, Wu T, Gluckman E, Soulier J, Surralles J, et al. Clinical and Molecular Characteristics of Squamous Cell Carcinomas From Fanconi Anemia Patients. J Nat Cancer Inst. 2008; 100: 1649-1653.
38. th ed. Vol. 2. Philadelphia (PA): Lippincott Williams & Wilkins; 2001; 2231-2264.
39. Munger K. The role of human papillomaviruses in human cancers. Front Biosci. 2002; 7: 641-649.
40. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 2002; 347: 1645-1651.
41. Lowy DR, Frazer IH. Chapter 16: Prophylactic human papillomavirus vaccines. J Natl Cancer Inst Monogr. 2003; 31: 111-116.
42. Duensing S, Munger K. The human papillomavirus type 16 E6 and E7oncoproteins independently induce numerical and structural chromosome instability. Cancer Res. 2002; 62: 7075-7082.
43. Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope. 1999; 109: 1544-1551.
44. D'Andrea AD. The Fanconi road to cancer. Genes Dev.2003; 17: 1933-1936.
45. Riley RR, Duensing S, Brake T, Munger K, Lambert PF, Arbeit JM.Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Res. 2003; 63: 4862-4871.